This includes questions about your symptoms, medical history, and any medications you're currently taking
In the US, treatment is typically recommended for those with a T-score of -2.5, a history of hip or vertebral fracture, or a FRAX 10-year probability of 3% for hip fracture or 20% for major osteoporotic fracture
This non-surgical weight loss approach may not produce results for everyone
Left unchecked, high blood sugar can damage blood vessels, the nervous and immune systems, as well as impact multiple organs
Online communities report several common profiles among semaglutide microdosers: Side effect sensitive: Those experiencing severe nausea even at 0.25mg Slow titrators: People needing longer adjustment periods between doses Maintenance optimizers: Post-weight-loss users seeking minimum effective doses Cost-conscious users: Those stretching supply due to affordability Reported Outcomes Commonly Reported Benefits: Reduced nausea intensity More consistent appetite suppression Fewer "hungry days" before next dose Better energy stability Commonly Reported Challenges: Injection fatigue and site irritation Difficulty calculating doses Confusion tracking medication Slower weight loss for some Common Protocols Reported Sunday/Wednesday: Popular for twice-weekly splitting Monday/Thursday: Alternative twice-weekly schedule Mon/Wed/Fri: Thrice-weekly with work-week alignment "As needed": Controversial approach based on hunger signals Safety concerns in community use: Many use compounded semaglutide of uncertain quality Dose calculations often based on community advice, not medical guidance Some combine semaglutide with other GLP-1 agonists Lack of monitoring for rare but serious complications Making an Informed Decision Questions to Consider If you're contemplating microdosing semaglutide, ask yourself: Have I tried standard titration protocols first
Weight regain and cardiometabolic effects after withdrawal of semaglutide: STEP 1 trial extension
